News for Sangamo Therapeutics Inc

TipRanks 5d

Biotech Alert: Searches spiking for these stocks today

TipRanks 6d

Biotech Alert: Searches spiking for these stocks today

TipRanks 7d

Truist Financial Reaffirms Their Buy Rating on Sangamo Biosciences (SGMO)

TipRanks 7d

Sangamo price target lowered to $5 from $9 at Barclays

TipRanks 7d

Analysts Offer Insights on Healthcare Companies: Sangamo Biosciences (SGMO), UnitedHealth (UNH) and Adaptimmune Therapeutics (ADAP)

TipRanks 8d

RBC Capital Keeps Their Hold Rating on Sangamo Biosciences (SGMO)

Seeking Alpha 8d

Sangamo Therapeutics prices $23M securities offering

Seeking Alpha 8d

Sangamo Therapeutics misses top-line and bottom-line estimates; reaffirms FY25 outlook

TipRanks 8d

Sangamo reports Q1 EPS (14c) vs (27c) last year

TipRanks 8d

Sangamo backs FY25 operating expenses view $135M-$155M

Seeking Alpha 9d

Here are the major earnings after the close today

Seeking Alpha 9d

Sangamo Therapeutics Q1 2025 Earnings Preview

Seeking Alpha 10d

Earnings week ahead: PLUG, CSCO, WMT, BABA, AMAT, JD, TCEHY, and more

TipRanks 12d

Largest borrow rate increases among liquid names

TipRanks 14d

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Iradimed (IRMD) and Sangamo Biosciences (SGMO)

TipRanks 16d

H.C. Wainwright Remains a Buy on Sangamo Biosciences (SGMO)

TipRanks 35d

Largest borrow rate increases among liquid names

TipRanks 43d

Largest borrow rate increases among liquid names

TipRanks 43d

Biotech Alert: Searches spiking for these stocks today

TipRanks 47d

Morning Movers: Rout continues as China hits back at Trump tariffs

TipRanks 47d

Closing Bell Movers: Futures continues to slip ahead of key jobs data

Seeking Alpha 47d

Eli Lilly to leverage Sangamo capsid technology for CNS disease therapies

TipRanks 47d

Sangamo up 53% to 95c after announcing license pact with Eli Lilly

TipRanks 47d

Sangamo announces capsid license agreement with Eli Lilly

TipRanks 63d

Truist Financial Sticks to Its Buy Rating for Sangamo Biosciences (SGMO)

TipRanks 63d

3 Best Stocks to Buy Now, 3/19/2025, According to Top Analysts

TipRanks 64d

RBC Capital Sticks to Their Hold Rating for Sangamo Biosciences (SGMO)

TipRanks 64d

3 Best Stocks to Buy Now, 3/18/2025, According to Top Analysts

TipRanks 64d

Sangamo Biosciences (SGMO) Gets a Hold from Wells Fargo

TipRanks 64d

Barclays Sticks to Its Buy Rating for Sangamo Biosciences (SGMO)

TipRanks 64d

Closing Bell Movers: Harrow spikes 24% on revenue beat, leverage update

Seeking Alpha 64d

Sangamo Therapeutics GAAP EPS of -$0.11 misses by $0.02, revenue of $7.55M misses by $4.15M

TipRanks 64d

Sangamo reports Q4 EPS (11c) vs (34c) last year

TipRanks 64d

Sangamo sees FY25 operating expenses $135M-$155M

TipRanks 64d

Sangamo options imply 29.8% move in share price post-earnings

Seeking Alpha 65d

Here are the major earnings after the close today

TipRanks 65d

Options Volatility and Implied Earnings Moves Today, March 17, 2025

TipRanks 65d

Options Volatility and Implied Earnings Moves This Week, March 17 – March 21, 2025

Seeking Alpha 65d

Sangamo Therapeutics Q4 Earnings Preview

Seeking Alpha 66d

Earnings week ahead: FDX, GIS, NIO, XPEV, MU, NKE, CCL, ACN and more

Seeking Alpha 80d

Earnings week ahead: TGT, COST, CRWD, AVGO, JD, PLUG, MRVL, and more

TipRanks 103d

TD Cowen Sticks to Its Buy Rating for Sangamo Biosciences (SGMO)

Seeking Alpha 103d

Sangamo reports updated data for gene therapy candidate ST-920

TipRanks 104d

Sangamo announces updated data from STAAR study

TipRanks 114d

Sangamo Biosciences Receives ‘Buy’ Rating from Patrick Trucchio Amid Anticipated Collaborations and Gene Therapy Advances

TipRanks 118d

Sangamo price target lowered to $5 from $7 at Truist

TipRanks 118d

Truist Financial Keeps Their Buy Rating on Sangamo Biosciences (SGMO)

TipRanks 124d

Sangamo Biosciences Holds Steady Amid Partnership Prospects and Program Uncertainties

Seeking Alpha 130d

Gene editing stocks drop as Intellia announces layoffs

TipRanks 137d

Biotech Alert: Searches spiking for these stocks today

	
		OSZAR »